In last trading session, Oncology Institute Inc (NASDAQ:TOI) saw 1.93 million shares changing hands with its beta currently measuring -0.38. Company’s recent per share price level of $3.23 trading at $0.35 or 12.15% at ring of the bell on the day assigns it a market valuation of $244.68M. That closing price of TOI’s stock is at a premium of 8.36% from its 52-week high price of $2.96 and is indicating a premium of 95.98% from its 52-week low price of $0.13. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.36 million shares which gives us an average trading volume of 856.68K if we extend that period to 3-months.
For Oncology Institute Inc (TOI), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.
Oncology Institute Inc (NASDAQ:TOI) trade information
Upright in the green during last session for gaining 12.15%, in the last five days TOI remained trading in the green while hitting it’s week-highest on Thursday, 04/24/25 when the stock touched $3.23 price level, adding 7.71% to its value on the day. Oncology Institute Inc’s shares saw a change of 945.31% in year-to-date performance and have moved 66.49% in past 5-day. Oncology Institute Inc (NASDAQ:TOI) showed a performance of 156.35% in past 30-days. Number of shares sold short was 1.29 million shares which calculate 2.36 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 8 to the stock, which implies a rise of 59.62% to its current value. Analysts have been projecting 6 as a low price target for the stock while placing it at a high target of 10. It follows that stock’s current price would drop -85.76% in reaching the projected high whereas dropping to the targeted low would mean a loss of -85.76% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -488.57% during past 5 years.
Oncology Institute Inc (NASDAQ:TOI)’s Major holders
Insiders are in possession of 14.52% of company’s total shares while institution are holding 35.76 percent of that, with stock having share float percentage of 41.84%. Investors also watch the number of corporate investors in a company very closely, which is 35.76% institutions for Oncology Institute Inc that are currently holding shares of the company. FMR LLC is the top institutional holder at TOI for having 4.75 million shares of worth $2.19 million. And as of 2024-06-30, it was holding 6.4005 of the company’s outstanding shares.
The second largest institutional holder is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), which was holding about 3.36 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.5263 of outstanding shares, having a total worth of $1.55 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 1.27 shares of worth $4.11 million or 1.68% of the total outstanding shares. The later fund manager was in possession of 422.98 shares on Dec 31, 2024 , making its stake of worth around $1.37 million in the company or a holder of 0.56% of company’s stock.
